MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,182 | -61.4% | 178,096 | 0.0% | 0.00% | – |
| Q2 2023 | $585,936 | -17.3% | 178,096 | +3.4% | 0.00% | – |
| Q1 2023 | $708,137 | -35.6% | 172,296 | -8.2% | 0.00% | -100.0% |
| Q4 2022 | $1,099,899 | -11.6% | 187,696 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $1,244,000 | +51.3% | 183,996 | +3.4% | 0.00% | 0.0% |
| Q2 2022 | $822,000 | +51.4% | 177,996 | +30.9% | 0.00% | – |
| Q1 2022 | $543,000 | -30.9% | 135,996 | +7.6% | 0.00% | – |
| Q4 2021 | $786,000 | -32.2% | 126,396 | +2.8% | 0.00% | -100.0% |
| Q3 2021 | $1,160,000 | -29.3% | 122,996 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $1,640,000 | -19.1% | 120,796 | -3.6% | 0.00% | 0.0% |
| Q1 2021 | $2,027,000 | -38.4% | 125,296 | +1.3% | 0.00% | -50.0% |
| Q4 2020 | $3,292,000 | +52.7% | 123,696 | +6.8% | 0.00% | 0.0% |
| Q3 2020 | $2,156,000 | -17.8% | 115,796 | +3.3% | 0.00% | 0.0% |
| Q2 2020 | $2,623,000 | – | 112,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |